Search Results 2031-2040 of 21780 for platelets

1. Chemotherapy Alone or Chemotherapy Plus Radiation Therapy in Treating Patients with Locally Advanced Rectal Cancer Undergoing Surgery - Mayo Clinic

   Platelet count ≥ 100,000/mm^3; Hemoglobin > 8.0 g/dL; Total bilirubin ≤ 1.5 x upper limit of normal (ULN); SGOT (AST) ≤ 3 x ULN; SGPT (ALT) ≤ 3 x ULN ...

2. Inotuzumab Ozogamicin and Frontline Chemotherapy in Treating Young Adults With Newly Diagnosed B Acute Lymphoblastic Leukemia - Mayo Clinic

   Platelet count >= 100,000/mm^3. Total bilirubin =< 1.5 x upper limit of normal (ULN), except for patients with known Gilbert's syndrome. Aspartate ...

3. A Study of Paclitaxel with or without Cixutumumab as Second-Line Therapy for Treating Patients with Metastatic Esophageal Cancer or Gastroesophageal Junction Cancer - Mayo Clinic

   Platelets ≥ 100,000/mcL; Total bilirubin ≤ institutional upper limit of normal (ULN); Aspartate transaminase (AST) (serum glutamic oxaloacetic transaminase ...

4. Combination Therapy Of Pegylated Interferon Alfa-2a And Tenofovir Versus Tenofovir Monotherapy In Chronic Hepatitis B - Mayo Clinic

   Platelet count <90,000 /mm3, hemoglobin <13 g/dL (males) or <12 g/dL (females), absolute neutrophil count <1500 /mm3 (<1000/mm3 for African-Americans) ...

5. Doxorubicin and Cyclophosphamide Followed By Trastuzumab, Paclitaxel, and Lapatinib in Treating Patients With Early-Stage HER2-Positive Breast Cancer That Has Been Removed By Surgery - Mayo Clinic

   Platelet count ≥ 100,000/mm³; Hemoglobin ≥ 10.0 g/dL; Bilirubin ≤ 1.5 times upper limit of normal (ULN); AST and ALT ≤ 2.5 times ULN; Alkaline phosphatase ...

6. A Study of Tazemetostat in Treating Patients With Recurrent Ovarian, Primary Peritoneal, or Endometrial Cancer - Mayo Clinic

   Platelets ≥ 100,000/mcl (within 14 days prior to registration). Absolute neutrophil count (ANC) ≥ 1,500/mcl (within 14 days prior to registration) ...

7. Cyclophosphamide, Ixazomib, and Dexamethasone in Treating Patients With Previously Untreated Symptomatic Multiple Myeloma - Mayo Clinic

   Platelet count ≥ 75000/mm^3; Hemoglobin ≥ 8.0 g/dL; Total bilirubin ≤ 1.5 x upper limit of normal (ULN); Alanine aminotransferase (ALT) and aspartate ...

8. A Study Comparing Temozolomide and Selumetinib for Treating Patients with Metastatic Melanoma of the Eye - Mayo Clinic

   Platelets ≥ 100,000/mcL; Hemoglobin ≥ 9.0 g/dL (not requiring transfusions within the past 2 weeks); Total bilirubin ≤ 1.5 times upper limit of normal.

9. A Study to Evaluate CB-839 With Radiation Therapy and Temozolomide in Treating Participants With IDH-Mutated Diffuse Astrocytoma or Anaplastic Astrocytoma - Mayo Clinic

   Platelets >= 100 x 10^9/L. International normalized ratio (INR) =< 1.5 x upper limit of normal (ULN). Partial thromboplastin time (PTT) or activated partial ...

10. Neurosurgery - Clinical trials

    ... platelets ≥ 100,000 /microliter, performed within 7 days prior to the collection. Pagination Clinical studies. PrevPrevious Page · Go to page 11 · Go to page 2 ...